Australia - English - Department of Health (Therapeutic Goods Administration)

everform therapywear holdings pty ltd - 60426 - dressing-supportive upper-body garment - posture support maternity and nursing bra. designed to reflect the australian breastfeeding association recommendation for underwire free for maternity and nursing, this bra goes much further to support a womans changing body in the pregnancy to breastfeeding journey. bra (breast research australia) also recommends wearing 2 bras for women with a d or greater bust size for mid- high impact - so we have created a "bra within a bra" design which is reflected in a high impact support design with a hidden, adjustable postural support under layer to add increased breast support and increased postural awareness and support. the bra is also highly adjustable in the frame (waistband) to allow for rib cage fluctuations from pregnancy to postpartum, and has adjustable feeding panels to allow for changes in breast volume pre to post feed, as well as early to late breastfeeding and the desired support level - medium to high.

Australia - English - Department of Health (Therapeutic Goods Administration)

everform therapywear holdings pty ltd - 60425 - dressing-supportive lower-body garment - posturally supportive pregnancy leggings, anatomical panels to support sacroiliac joint, lumbar spine, bump support and assist venous return. .

Australia - English - Department of Health (Therapeutic Goods Administration)

everform therapywear holdings pty ltd - 60425 - dressing-supportive lower-body garment - posturally supportive post - pregnancy support shorts, with anatomical panels to support the pelvic floor and abdominal region, with additional sacroiliac joint, lumbar spine, and venous return support.

Australia - English - Department of Health (Therapeutic Goods Administration)

everform therapywear holdings pty ltd - 60425 - dressing-supportive lower-body garment - posturally supportive pregnancy shorts, anatomical panels to support pelvic floor, sacroiliac joint, lumbar spine, bump support and assist venous return. absorbent gusset for light bladder leakage.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: maize starch; purified talc; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; quinoline yellow aluminium lake; lactose monohydrate; hypromellose; crospovidone; titanium dioxide; macrogol 6000 - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: magnesium stearate; purified talc; microcrystalline cellulose; lactose monohydrate; crospovidone; maize starch; hypromellose; titanium dioxide; sunset yellow fcf aluminium lake; colloidal anhydrous silica; macrogol 6000; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: magnesium stearate; colloidal anhydrous silica; hypromellose; microcrystalline cellulose; crospovidone; maize starch; purified talc; lactose monohydrate; brilliant blue fcf aluminium lake; titanium dioxide; macrogol 6000 - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

United States - English - NLM (National Library of Medicine)

pai holdings, llc - nortriptyline hydrochloride (unii: 00fn6ih15d) (nortriptyline - unii:bl03sy4lxb) - nortriptyline 10 mg in 5 ml - nortriptyline hydrochloride oral solution is indicated for the relief of symptoms of depression. endogenous depressions are more likely to be alleviated than are other depressive states. the use of maois intended to treat psychiatric disorders with nortriptyline hydrochloride oral solution or within 14 days of stopping treatment with nortriptyline hydrochloride oral solution is contraindicated because of an increased risk of serotonin syndrome. the use of nortriptyline hydrochloride oral solution within 14 days of stopping an maoi intended to treat psychiatric disorders is also contraindicated (see warnings and dosage and administration ). starting nortriptyline hydrochloride oral solution in a patient who is being treated with maois such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome (see warnings and dosage and admini

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; iron oxide red; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. entrip 50mg tablets are indicated only for the maintenance treatment of major depression (see precautions). nocturnal enuresis where organic pathology has been excluded.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; microcrystalline cellulose; maize starch; croscarmellose sodium; colloidal anhydrous silica; purified talc; magnesium stearate; macrogol 6000; hypromellose; titanium dioxide; iron oxide yellow; polyvinyl alcohol; macrogol 3350 - for the treatment of major depression. nocturnal enuresis where organic pathology has been excluded.